Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Russell Health is a regenerative medicine company that specializes in the distribution and development of amniotic-derived biological products. The company's portfolio includes Stem-Flow, an acellular liquid allograft, and Stem-Wrap, a dehydrated amniotic membrane, which are used to treat orthopedic conditions, chronic pain, and complex wounds. By leveraging the natural healing properties of birth tissue-derived growth factors and cytokines, Russell Health provides minimally invasive alternatives to traditional surgical interventions. The company serves a broad range of clinical specialties, including sports medicine, podiatry, and pain management. Their products are designed to support the body's natural repair processes and improve patient outcomes without the need for invasive surgery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Russell Health.